Literature DB >> 25585261

Inflaming the diseased brain: a role for tainted melanins.

T M Jeitner1, M Kalogiannis2, P A Patrick3, I Gomolin4, T Palaia5, L Ragolia5, D Brand3, E J Delikatny6.   

Abstract

Inflammation plays a crucial role in neurodegenerative diseases, but the irritants responsible for this response remain largely unknown. This report addressed the hypothesis that hypochlorous acid reacts with dopamine to produce melanic precipitates that promote cerebral inflammation. Spectrophotometric studies demonstrated that nM amounts of HOCl and dopamine react within seconds. A second-order rate constant for the reaction of HOCl and dopamine of 2.5 × 10(4)M(-1)s(-1) was obtained by measuring loss of dopaminergic fluorescence due to HOCl. Gravimetric measurements, electron microscopy, elemental analysis, and a novel use of flow cytometry confirmed that the major product of this reaction is a precipitate with an average diameter of 1.5 μm. Flow cytometry was also used to demonstrate the preferential reaction of HOCl with dopamine rather than albumin. Engulfment of the chlorodopamine particulates by phagocytes in vitro caused these cells to release TNFα and die. Intrastriatal administration of 10(6) particles also increased the content of TNFα in the brain and led to a 50% loss of the dopaminergic neurons in the nigra. These studies indicate that HOCl and dopamine react quickly and preferentially with each other to produce particles that promote inflammation and neuronal death in the brain.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain; Dopamine; Hypochlorous acid; Inflammation; Parkinson disease

Mesh:

Substances:

Year:  2015        PMID: 25585261      PMCID: PMC5113040          DOI: 10.1016/j.bbadis.2015.01.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

1.  Depletion of neutrophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo.

Authors:  Jae K Ryu; Karen C Tran; James G McLarnon
Journal:  Glia       Date:  2007-03       Impact factor: 7.452

2.  Evidence for specific phases in the development of human neuromelanin.

Authors:  G M Halliday; H Fedorow; C H Rickert; M Gerlach; P Riederer; K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

3.  Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants.

Authors:  Yasunori Iwao; Yu Ishima; Junji Yamada; Taishi Noguchi; Ulrich Kragh-Hansen; Katsumi Mera; Daisuke Honda; Ayaka Suenaga; Toru Maruyama; Masaki Otagiri
Journal:  IUBMB Life       Date:  2012-02-20       Impact factor: 3.885

4.  Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells.

Authors:  Eugene V Mosharov; Liang-Wei Gong; Bhavanna Khanna; David Sulzer; Manfred Lindau
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 5.  Modulation of alpha-synuclein aggregation by dopamine: a review.

Authors:  Su Ling Leong; Roberto Cappai; Kevin Jeffrey Barnham; Chi Le Lan Pham
Journal:  Neurochem Res       Date:  2009-05-15       Impact factor: 3.996

Review 6.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

Review 7.  Hypochlorite-induced oxidation of amino acids, peptides and proteins.

Authors:  C L Hawkins; D I Pattison; M J Davies
Journal:  Amino Acids       Date:  2003-07-29       Impact factor: 3.520

8.  Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.

Authors:  Charlotte Laloux; Philippe Derambure; Elise Houdayer; Jean-Marie Jacquesson; Régis Bordet; Alain Destée; Christelle Monaca
Journal:  J Sleep Res       Date:  2008-03       Impact factor: 3.981

9.  Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.

Authors:  Michael O Breckwoldt; John W Chen; Lars Stangenberg; Elena Aikawa; Elisenda Rodriguez; Shumei Qiu; Michael A Moskowitz; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

10.  Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Authors:  A Kastner; E C Hirsch; O Lejeune; F Javoy-Agid; O Rascol; Y Agid
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

View more
  5 in total

1.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

2.  Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis.

Authors:  Chenwen Shao; Jiwen Yuan; Yani Liu; Yajuan Qin; Xueao Wang; Jin Gu; Guiquan Chen; Bing Zhang; Hong-Ke Liu; Jing Zhao; Hai-Liang Zhu; Yong Qian
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-23       Impact factor: 11.205

3.  Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Ana Luisa Gavito; Antonio Córdoba-Fernández; José Chacón; Ángel Martín de Pablos
Journal:  Antioxidants (Basel)       Date:  2022-05-30

4.  Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.

Authors:  Thomas M Jeitner; Mike Kalogiannis; Boris F Krasnikov; Irving Gomolin; Morgan R Peltier; Graham R Moran
Journal:  Toxicol Sci       Date:  2016-03-29       Impact factor: 4.849

5.  Gamma-irradiation produces active chlorine species (ACS) in physiological solutions: Secoisolariciresinol diglucoside (SDG) scavenges ACS - A novel mechanism of DNA radioprotection.

Authors:  Om P Mishra; Anatoliy V Popov; Ralph A Pietrofesa; Melpo Christofidou-Solomidou
Journal:  Biochim Biophys Acta       Date:  2016-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.